References
-
Cantello, B. C., Cawthorne, M. A., Cottam, G. P., Duff, P. T., Haigh, D., Hindley, R. M., Lister, C. A., Snith, S. A., and Thurlby, P. L., [[
${\omega}$ -(Heterocyclylamino)alkoxy]benzyl]-2,4- thiazolidinediones as potent antihyperglycemic agents. J. Med. Chem., 37, 3977-3985 (1994) https://doi.org/10.1021/jm00049a017 - Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., and Tannenbaum, S. R., Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem., 126, 131-138 (1982) https://doi.org/10.1016/0003-2697(82)90118-X
- Heneka, M. T., Feinstein, D. L., Galea, E., Gleichmann, M., Wullner, U., and Klockgether, T., Peroxisome proliferatoractivated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase. Journal of Neuroimmunology, 100, 156-168 (1999) https://doi.org/10.1016/S0165-5728(99)00192-7
- Henke, B. R., Blanchard, S. G., Brackeen, M. F., Brown, K. K., Cobb, J. E., Collins, J. L. Jr., Harrington, W. W., Hashim, M. A., Hull-Ryde, E. A., Kaldor, I., Kliewer, S. A., Lake, D. H., Leesnitzer, L. M., Lehmann, J. M., Lenhard, J. M., Orband- Miller, L. A., Miller, J. F., Mook, R. A. Jr., Noble, S. A., Oliver, W. Jr., Parks, D. J., Plunket, K. D., Szewczyk, J. R., and Willson, T. M., N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. J. Med. Chem., 41, 5020-5036 (1998) https://doi.org/10.1021/jm9804127
- Jeon, R. and Park, S., Synthesis and biological activity of benzoxazole containing thiazolidinedione derivatives. Arch. Pharm. Res., 27, 1099-1105 (2004) https://doi.org/10.1007/BF02975111
-
Lehmann, J. M., Moorre, L. B., Smith-Oliver, T. A., Wilkinson, W. O., Wilson, T. M., and Kliewer, S. A., An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor
${\gamma}(PPAR{\gamma})$ . J. Biol. Chem., 270, 12953-12956 (1995) https://doi.org/10.1074/jbc.270.22.12953 - Lohray, B. B., Bhushan, V., Rao, B. P., Madhavan, G. R., Murali, N., Rao, K. N., Reddy, A. K., Rajesh, B. M., Reddy, P. G., Chakrabarti, R., Vikramadithyan, R. K., Rajagopalan, R., Mamidi, R. N., Jajoo, H. K., and Subramaniam, S., Novel euglycemic and hypolipidemic agents. 1. J. Med. Chem., 41, 1619-1630 (1998) https://doi.org/10.1021/jm970444e
- Morita, H., Mori, H., and Kobayashi, Y., Process for the production of a thiazolidinedione derivative, GB 2324089A (1998)
- Oguchi, M., Wada, K., Honma, H., Tanaka, A., Kaneko, T., Sakakibara, S., Ohsumi, J., Serizawa, N., Fujiwara, T., Horikoshi, H., and Fujita, T., Molecular design, synthesis, and hypoglycemic activity of a series of thiazolidine-2,4-diones. J. Med. Chem., 43, 3052-3066 (2000) https://doi.org/10.1021/jm990522t
- Reaven, G. M., Chang, H., and Hoffman, B. B., Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes. Diabetes, 37, 28-32 (1988) https://doi.org/10.2337/diabetes.37.1.28
- Sohda, T., Momose, Y., Meguro, K., Kawamatsu, Y., Sugiyama, Y., and Ikeda, H., Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4- thiazolidinediones. Arzneim.-Forsch., 40, 37-42 (1990)
- Yoshioka, T., Fujita, T., Kanai, T., Aizawa, Y., Kurumada, T., Hasegawa, K., and Horikoshi, H., Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation. J. Med. Chem., 32, 421-428 (1989) https://doi.org/10.1021/jm00122a022